Dear Editor, Syringomyelia is a rare delayed complication of tubercular meningitis (TBM) and develops 7-28 years after the occurrence of TBM. [1] Early syringomyelia during active disease or while continuing antituberculosis therapy (ATT) is even rarer. [2] Multiseptated syringomyelia has been reported in the literature in association with trauma and after spinal surgical procedures for extramedullary lesions and meningomyelocele but not with TBM. [3, 4] We present a rare case of a 6-year-old boy with TBM developing multiseptated cervico-dorsal syringomyelia during the continuation phase of the ATT.
The child presented with difficulty in walking, blurring of vision, multiple seizure episodes, headache, and intermittent vomiting for 1 month. He had a history of contact with tuberculosis. The contrast-enhanced computed tomography scan of the brain showed basal exudates and communicating hydrocephalus. The cerebrospinal fluid (CSF) analysis revealed increased protein and lymphocytosis. Staining for acid-fast bacilli was negative. He was diagnosed with TBM and was started on ATT. Ventriculoperitoneal shunt surgery was performed after 4 months of starting ATT due to persistent headache and clinico-radiological features of raised intracranial pressure. The patient again presented with paraparesis after a month. On examination, he was afebrile, conscious, and oriented. There was no neck rigidity or cranial nerve palsy. Tone was normal in bilateral upper limbs, and bilateral lower limbs were spastic. All the limbs had power 4/5. The reflexes and the sensory examination were normal. Cerebellar signs and papilledema were absent. Magnetic resonance imaging (MRI) of the brain and the spine was conducted to rule out compressive myelopathy.
The sagittal T2-weighted MRI of the spine showed a long segment, hyperintense, multiseptated intramedullary lesion, involving the cervico-dorsal cord [ Figure 1 ] without cord expansion, which was hypointense on T1-weighted image, suggestive of syringomyelia. No basal exudates or tuberculomas were noted in the brain.
The patient was continued on ATT and steroid. There was improvement in the tone and power of the limbs during follow-up at 3 months and he was able to walk without support.
The probable mechanisms of syrinx development in TBM are tubercular vasculitis, producing cord ischemia and softening; spinal subarachnoid space scarring, causing reduced compliance of the subarachnoid space; and the patent Virchow-Robin spaces in the spinal cord, providing a channel for the CSF to enter into the central canal and communicating hydrocephalus with acute rise in intracranial pressure. [2, 5] The other spinal complications of TBM are arachnoiditis, vasculitic infarcts, and tuberculomas.
The exact cause of development of septations in our case was not known but could be due to adhesions as a result of inflammation.
Post-tubercular syringomyelia has no medical treatment and may require surgery if a stable clinical state is not achieved. [6] Onset of neurological symptoms such as paraparesis indicates spinal cord involvement, and the possibility of syringomyelia should be kept in mind as a rare early complication of TBM as seen in our case.
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Transient Hemiparesis: A Rare Complication of Phenytoin Intoxication
Dear Editor, An 8-year-old boy presented with a seizure after a fall from a height. Neuroimaging revealed a fracture of the left parietal bone with underlying brain injury. The child was started on oral phenytoin in a dose of 6 mg/kg/day and discharged from hospital without any neurological deficit. Seven months later, he developed unsteady gait, headache, and giddiness. He was hospitalized and a repeat neuroimaging was performed, which was found to be normal. He was continued on oral phenytoin although the symptoms persisted.
Three months later, the child presented to the emergency with altered sensorium of 12 h following an episode of generalized tonic-clonic seizure. Examination revealed heart rate, 88/min; respiratory rate, 20/min; temperature, 37.2°C; blood pressure, 108/72 mm Hg; and pulse oximetry reading, 97% (on room air). Both the pupils were normal in size and were reacting to light stimulus; the fundus was unremarkable. Central nervous system examination revealed a Glasgow Coma Scale (GCS) score of 9 (E2V3M4), absence of signs of raised intracranial pressure or meningeal irritation. Palsy of the right facial nerve (upper motor neuron type) and weakness of right upper and lower limbs with increased muscle tone were noted. The deep tendon reflexes were brisk and an extensor plantar response was found on the right side. Laboratory investigations revealed hemoglobin, 10.4 g/dL; total leucocyte count, 11,000/mm ; venous blood sugar, 88 mg/dL; serum calcium, 9 mg/dL; blood urea, 15 mg/dL; serum creatinine, 0.8 mg/dL; serum glutamic-oxaloacetic transaminase, 34 U/L; serum glutamine pyruvic transaminase, 36 U/L; serum protein, 4.5 mg/dL; serum albumin, 2.5 mg/ dL; serum bilirubin, 0.8 mg/dL; prothrombin time, 12 s; and partial thromboplastin time, 29 s. Chest radiograph and computed tomography of the brain were normal. A possibility of phenytoin toxicity was entertained and therefore phenytoin was discontinued and intravenous valproate was started. Serum phenytoin levels were 66 ng/mL (normal reference range, 10-20 ng/mL). After 72 h of hospitalization, the child's sensorium improved with a GCS score of 13 (E4V4M5) but the right-sided hemiparesis persisted. The serum phenytoin levels assessed after 72 h of discontinuation of phenytoin had decreased to 48 ng/mL. Subsequently, his condition gradually improved; the confusion cleared and the hemiparesis improved.
Phenytoin is a broad-spectrum anticonvulsant drug, which is particularly popular in developing countries as it is cost-effective. Phenytoin toxicity commonly manifests as nausea, vomiting, and mild central nervous system dysfunction, particularly nystagmus, ataxia, confusion, dysarthria, depressed conscious state coma, and seizures; serious adverse events including fatalities are rarely reported. At therapeutic doses,
